| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
20,526 |
19,171 |
$3.85M |
| 36415 |
Collection of venous blood by venipuncture |
70,591 |
29,260 |
$2.26M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
8,941 |
8,547 |
$1.77M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
6,281 |
5,507 |
$1.54M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
10,659 |
10,005 |
$1.44M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
6,829 |
2,694 |
$1.43M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,352 |
3,253 |
$1.10M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
4,379 |
3,582 |
$950K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,485 |
3,383 |
$862K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
731 |
723 |
$752K |
| 80053 |
Comprehensive metabolic panel |
28,893 |
24,934 |
$751K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,291 |
2,249 |
$673K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
1,083 |
503 |
$664K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,073 |
2,026 |
$652K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
1,093 |
1,079 |
$581K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,312 |
1,279 |
$540K |
| 81025 |
|
2,881 |
2,792 |
$527K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
5,991 |
5,819 |
$419K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,283 |
1,261 |
$395K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,380 |
1,011 |
$395K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
2,027 |
1,880 |
$389K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
966 |
965 |
$364K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,925 |
1,868 |
$355K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,453 |
3,329 |
$336K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
7,288 |
6,834 |
$307K |
| 59025 |
Fetal non-stress test |
916 |
693 |
$306K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
3,323 |
1,437 |
$285K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
3,712 |
1,495 |
$276K |
| 97162 |
|
1,031 |
1,023 |
$265K |
| 93975 |
|
680 |
670 |
$229K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
2,691 |
2,624 |
$196K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
3,809 |
3,580 |
$161K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,731 |
1,695 |
$149K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
4,573 |
4,296 |
$123K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,334 |
1,333 |
$111K |
| 76801 |
|
1,052 |
927 |
$109K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
3,033 |
2,971 |
$107K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
4,468 |
4,246 |
$98K |
| 76830 |
Ultrasound, transvaginal |
1,429 |
1,397 |
$92K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
4,316 |
3,994 |
$88K |
| 84443 |
Thyroid stimulating hormone (TSH) |
8,891 |
8,538 |
$87K |
| 86900 |
|
1,731 |
1,639 |
$85K |
| 88342 |
|
224 |
220 |
$85K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
2,951 |
2,944 |
$83K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
2,537 |
2,338 |
$83K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,945 |
3,334 |
$77K |
| 96367 |
|
738 |
618 |
$75K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
28,936 |
24,239 |
$75K |
| 80061 |
Lipid panel |
5,909 |
5,877 |
$74K |
| 12001 |
|
154 |
154 |
$73K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
3,030 |
2,968 |
$71K |
| 97161 |
|
311 |
303 |
$68K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
722 |
665 |
$58K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
554 |
536 |
$58K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
260 |
154 |
$56K |
| 83880 |
|
1,534 |
1,469 |
$47K |
| 86850 |
|
1,665 |
1,587 |
$43K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
5,117 |
5,069 |
$43K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
79 |
78 |
$42K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
788 |
771 |
$39K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
1,778 |
1,730 |
$38K |
| 71046 |
Radiologic examination, chest; 2 views |
5,256 |
5,092 |
$37K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
388 |
352 |
$36K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
332 |
283 |
$34K |
| G0378 |
Hospital observation service, per hour |
1,721 |
1,468 |
$33K |
| 82607 |
|
2,466 |
2,425 |
$32K |
| 82728 |
|
2,340 |
2,254 |
$30K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,283 |
1,283 |
$27K |
| 82746 |
|
2,048 |
2,008 |
$26K |
| 84439 |
|
2,880 |
2,848 |
$23K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,773 |
1,761 |
$22K |
| 71271 |
|
235 |
235 |
$21K |
| 93017 |
|
134 |
134 |
$21K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
5,947 |
5,558 |
$21K |
| 93971 |
|
339 |
328 |
$21K |
| 94060 |
|
82 |
82 |
$19K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
78 |
77 |
$19K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
487 |
482 |
$18K |
| 83550 |
|
2,372 |
2,305 |
$17K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
9,612 |
8,136 |
$16K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,918 |
1,797 |
$16K |
| 87480 |
|
1,062 |
1,031 |
$16K |
| 76770 |
|
79 |
79 |
$15K |
| 87510 |
|
1,049 |
1,019 |
$15K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
348 |
302 |
$15K |
| 90715 |
|
558 |
558 |
$15K |
| 85027 |
|
4,349 |
4,108 |
$15K |
| 87660 |
|
1,091 |
1,057 |
$15K |
| 71250 |
|
172 |
171 |
$15K |
| 83540 |
|
2,564 |
2,496 |
$14K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
7,402 |
6,770 |
$14K |
| 86803 |
|
1,618 |
1,606 |
$13K |
| 84702 |
|
1,891 |
1,452 |
$11K |
| 12002 |
|
24 |
24 |
$11K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
274 |
274 |
$11K |
| 86901 |
|
806 |
767 |
$11K |
| 81001 |
|
8,206 |
7,630 |
$10K |
| 86140 |
|
3,698 |
3,429 |
$9K |
| 87186 |
|
1,742 |
1,677 |
$8K |
| 73564 |
|
718 |
705 |
$8K |
| 94726 |
|
147 |
147 |
$8K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
290 |
156 |
$7K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,794 |
2,153 |
$7K |
| 85610 |
|
2,700 |
1,873 |
$7K |
| 84480 |
|
600 |
600 |
$7K |
| 83735 |
|
3,970 |
3,298 |
$7K |
| 87081 |
|
2,713 |
2,682 |
$7K |
| 74018 |
|
305 |
295 |
$7K |
| 87507 |
|
28 |
27 |
$7K |
| 85651 |
|
2,221 |
2,081 |
$6K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
15 |
15 |
$6K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
6,488 |
5,355 |
$5K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
24 |
24 |
$4K |
| 87340 |
|
910 |
905 |
$4K |
| 76641 |
|
44 |
43 |
$4K |
| 81003 |
|
6,130 |
5,861 |
$4K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
12 |
12 |
$4K |
| 71045 |
Radiologic examination, chest; single view |
4,790 |
4,591 |
$4K |
| 82570 |
|
778 |
757 |
$4K |
| 82043 |
|
632 |
631 |
$3K |
| 82962 |
|
2,552 |
1,400 |
$3K |
| 74183 |
|
12 |
12 |
$3K |
| 73130 |
|
793 |
778 |
$3K |
| 87468 |
|
81 |
81 |
$3K |
| 80076 |
|
366 |
355 |
$3K |
| 87070 |
|
527 |
517 |
$3K |
| 0352U |
|
153 |
150 |
$3K |
| 73610 |
|
945 |
919 |
$3K |
| 86780 |
|
210 |
206 |
$3K |
| 70496 |
|
13 |
13 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
443 |
332 |
$3K |
| 86762 |
|
503 |
497 |
$3K |
| 84481 |
|
185 |
185 |
$3K |
| 73630 |
|
854 |
838 |
$3K |
| 87449 |
|
127 |
124 |
$2K |
| 73030 |
|
370 |
363 |
$2K |
| 84403 |
|
78 |
76 |
$2K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
13 |
13 |
$2K |
| 88304 |
|
77 |
77 |
$2K |
| 87077 |
|
573 |
555 |
$2K |
| 87807 |
|
231 |
228 |
$2K |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
75 |
75 |
$2K |
| 84703 |
|
5,695 |
5,347 |
$2K |
| J1756 |
Injection, iron sucrose, 1 mg |
192 |
104 |
$2K |
| 83690 |
|
6,219 |
5,759 |
$2K |
| 83655 |
|
143 |
143 |
$2K |
| 87478 |
|
81 |
81 |
$2K |
| 87484 |
|
81 |
81 |
$2K |
| 87469 |
|
81 |
81 |
$2K |
| 70486 |
|
25 |
25 |
$1K |
| 72110 |
|
40 |
40 |
$1K |
| 73110 |
|
345 |
332 |
$1K |
| 82784 |
|
98 |
97 |
$1K |
| 84484 |
|
7,537 |
5,451 |
$1K |
| 85652 |
|
680 |
654 |
$1K |
| 86706 |
|
149 |
149 |
$1K |
| 82550 |
|
1,343 |
1,223 |
$1K |
| 87040 |
|
3,342 |
2,109 |
$1K |
| 86618 |
|
128 |
128 |
$927.99 |
| 87205 |
|
558 |
518 |
$851.01 |
| 82950 |
|
175 |
173 |
$824.19 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
17 |
17 |
$820.96 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,596 |
1,573 |
$796.07 |
| 70498 |
|
25 |
25 |
$789.43 |
| 97165 |
|
13 |
12 |
$787.63 |
| 86704 |
|
71 |
71 |
$703.21 |
| 83516 |
|
25 |
25 |
$685.36 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
366 |
223 |
$649.91 |
| 85378 |
|
1,437 |
1,408 |
$581.25 |
| 83605 |
|
3,948 |
3,416 |
$567.92 |
| 81002 |
|
287 |
277 |
$527.08 |
| 82105 |
|
40 |
40 |
$503.86 |
| 84100 |
|
548 |
437 |
$490.51 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
5,118 |
4,741 |
$466.72 |
| 84436 |
|
78 |
78 |
$463.44 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
13 |
13 |
$443.37 |
| 87521 |
Neg quan hep c or qual rna |
14 |
14 |
$437.56 |
| 86617 |
|
14 |
14 |
$423.15 |
| 83615 |
|
103 |
94 |
$413.97 |
| 85730 |
|
316 |
294 |
$413.04 |
| 85014 |
|
131 |
131 |
$377.47 |
| 84550 |
|
112 |
106 |
$361.58 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
622 |
455 |
$351.86 |
| 73590 |
|
91 |
90 |
$323.82 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
4,879 |
3,972 |
$303.39 |
| 85018 |
|
155 |
153 |
$297.37 |
| 86038 |
|
29 |
29 |
$297.31 |
| 94729 |
|
147 |
147 |
$288.14 |
| 80074 |
|
12 |
12 |
$267.98 |
| 84146 |
|
12 |
12 |
$266.84 |
| 82248 |
|
63 |
51 |
$266.60 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
602 |
597 |
$265.72 |
| 84152 |
|
13 |
13 |
$239.07 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,746 |
1,383 |
$223.79 |
| 84153 |
|
12 |
12 |
$169.19 |
| 88302 |
|
12 |
12 |
$165.20 |
| 86705 |
|
13 |
13 |
$150.89 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,601 |
1,297 |
$149.02 |
| 86431 |
|
28 |
28 |
$139.88 |
| 84479 |
|
24 |
24 |
$120.78 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
411 |
297 |
$105.87 |
| 85379 |
|
287 |
285 |
$105.62 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,705 |
2,239 |
$104.08 |
| 81015 |
|
41 |
38 |
$95.72 |
| 86308 |
|
110 |
110 |
$91.69 |
| 85007 |
|
77 |
69 |
$85.57 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
5,752 |
4,943 |
$83.92 |
| J7050 |
Infusion, normal saline solution, 250 cc |
685 |
479 |
$72.35 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
6,322 |
5,409 |
$70.44 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
776 |
588 |
$69.50 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
286 |
185 |
$66.89 |
| 76981 |
|
122 |
122 |
$60.28 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,414 |
1,298 |
$57.88 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,077 |
1,004 |
$57.54 |
| 82805 |
|
224 |
209 |
$55.57 |
| 86787 |
|
12 |
12 |
$53.03 |
| J2704 |
Injection, propofol, 10 mg |
5,962 |
3,762 |
$41.97 |
| 96376 |
|
2,394 |
1,613 |
$38.19 |
| 86592 |
|
12 |
12 |
$37.42 |
| 80143 |
|
1,316 |
1,229 |
$37.28 |
| 80179 |
|
1,276 |
1,197 |
$37.28 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,373 |
1,268 |
$29.17 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
246 |
173 |
$27.74 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
1,173 |
459 |
$24.74 |
| J1644 |
Injection, heparin sodium, per 1000 units |
663 |
318 |
$24.20 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
88 |
76 |
$18.82 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
351 |
301 |
$11.05 |
| J2060 |
Injection, lorazepam, 2 mg |
792 |
685 |
$9.19 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
90 |
49 |
$6.10 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
4,153 |
3,787 |
$6.02 |
| 82947 |
|
13 |
12 |
$4.72 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
384 |
336 |
$4.69 |
| 82272 |
|
12 |
12 |
$4.23 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
888 |
824 |
$1.63 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
2,370 |
2,213 |
$1.18 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
516 |
502 |
$0.30 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
1,440 |
1,336 |
$0.24 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
124 |
98 |
$0.16 |
| J3490 |
Unclassified drugs |
238 |
227 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
70 |
69 |
$0.00 |
| 73502 |
|
12 |
12 |
$0.00 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
24 |
24 |
$0.00 |
| J1815 |
Injection, insulin, per 5 units |
39 |
12 |
$0.00 |
| 82270 |
|
13 |
13 |
$0.00 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
38 |
30 |
$0.00 |
| J3372 |
Injection, vancomycin hcl (xellia), not therapeutically equivalent to j3370, 500 mg |
135 |
86 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
165 |
134 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
357 |
255 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
103 |
96 |
$0.00 |
| 73080 |
|
27 |
27 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
25 |
22 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
36 |
24 |
$0.00 |
| 82009 |
|
14 |
14 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
27 |
25 |
$0.00 |
| J2004 |
Injection, lidocaine hcl with epinephrine, 1 mg |
12 |
12 |
$0.00 |
| 73140 |
|
12 |
12 |
$0.00 |